The global life sciences industry is currently navigating an unprecedented technological schism precipitated by the formal dissolution of the nearly two-decade-long partnership between Veeva Systems and Salesforce. For the duration of this partnership, Veeva CRM operated as a highly specialized, industry-regulated managed package built directly upon the Salesforce Force.com platform. This shared architectural history defined how pharmaceutical and medical technology organizations structured their commercial operations, compliant sampling, and medical affairs. However, Veeva’s strategic decision to migrate its customer base to its proprietary Veeva Vault platform—coinciding with the expiration of Salesforce’s non-compete obligations in September 2025 and the ultimate end-of-life for Salesforce-based Veeva CRM in 2030—forces enterprise IT leaders into a critical infrastructural crossroads.
Organizations are now tasked with evaluating whether to follow Veeva into its standalone Vault ecosystem or to adopt the newly architected Salesforce Life Sciences Cloud (SFLSC). The latter represents a fundamental paradigm shift away from specialized, siloed applications toward a unified, AI-native platform ecosystem. Salesforce Life Sciences Cloud integrates core CRM functionalities with advanced conversational and agentic AI (Agentforce, Einstein GPT) and relies on the SFLSC Data Cloud architecture to provide a natively interoperable, single source of truth for healthcare providers (HCPs), healthcare organizations (HCOs), clinical trial participants, and therapeutic outcomes.
This comprehensive research report provides an exhaustive, expert-level blueprint for migrating data schemas, historical records, and operational workflows from the legacy Veeva CRM architecture to Salesforce Life Sciences Cloud. It details the profound conceptual differences in data modeling, provides explicit physical entity and column-level transformations, outlines architectural approaches for managing large data volumes (LDV) during extraction and loading, constructs a multi-year project phasing methodology, and identifies critical risk management strategies required for maintaining continuous regulatory compliance in pharmaceutical environments.
Conceptual Data Model Analysis of Veeva CRM vs. Salesforce Life Sciences Cloud
The architectural philosophies underlying Veeva CRM and Salesforce Life Sciences Cloud present distinctly different approaches to data management, system interoperability, and mobile performance optimization. Recognizing these conceptual differences is paramount before executing any physical data extraction, transformation, and load (ETL) procedures.
The historical Veeva CRM architecture relied on a managed package extension model. Standard Salesforce objects, predominantly Account and Contact, were heavily customized with hundreds of Veeva-specific metadata fields and proprietary custom objects (identified by the _vod__c suffix). Because these components were deployed via a managed package, their core schemas were immutable to the end-user, creating a tightly coupled data model tailored exclusively for pharmaceutical sales rep workflows. Crucially, the Veeva data model prioritized structural flatness. To ensure rapid offline synchronization for field representatives operating iPads in hospitals with poor connectivity, Veeva engineered massive, denormalized custom objects—such as the Call2_vod__c object—which captured visit details, attendees, samples, and medical inquiries within a single, wide record structure or through very tightly coupled child records.
Conversely, Salesforce Life Sciences Cloud leverages a deeply normalized, interoperable data model that aligns natively with broader healthcare informatics standards, specifically FHIR R4 and the United States Core Data for Interoperability (USCDI). Rather than relying on isolated, industry-specific custom objects, SFLSC builds upon the foundational architecture of Salesforce Health Cloud, extending standard objects with specialized life sciences capabilities. The SFLSC architecture relies heavily on polymorphic relationships, master-detail hierarchies, and junction objects to represent the complex, real-world networks inherent in modern healthcare.
The fundamental conceptual shifts that dictate the migration strategy include the transformation of interaction logging, the decoupling of provider network modeling, and the modernization of consent management. Where Veeva records an HCP interaction in a heavily populated, flat Call2_vod__c object , SFLSC requires ETL pipelines to normalize this data into a strict hierarchy encompassing the standard Visit object, the industry-specific ProviderVisit object, and execution data child records such as ProviderVisitProdDetailing and ProductDisbursement. Furthermore, SFLSC abandons the practice of storing HCP and HCO data purely as differentiated Account record types. Instead, it utilizes the Provider Relationship Management data model, separating the individual person from the clinical facility. An HCP is represented via a combination of Contact and HealthcareProvider records, while their working locations, admitting privileges, and institutional affiliations are mapped through junction objects like HealthcarePractitionerFacility, HealthcareFacility, and AccountContactRelation. Finally, Veeva’s reliance on bespoke consent objects, such as Multichannel_Consent_vod__c, is replaced in SFLSC by standard, cross-cloud privacy objects like AuthorizationFormConsent, enabling a unified privacy architecture that scales natively into Marketing Cloud and Data Cloud operations.
| Architectural Dimension | Veeva CRM (Force.com Managed Package) | Salesforce Life Sciences Cloud (Native Platform) | Migration Implication & Transformation Requirement |
|---|---|---|---|
| Object Architecture | Denormalized, flat custom objects (_vod__c) designed to minimize relational hops for legacy mobile sync optimization. | Highly normalized, FHIR R4-aligned relational schema utilizing deep master-detail and lookup hierarchies. | ETL pipelines must disaggregate single Veeva records (e.g., a Call) into multiple related SFLSC records, enforcing sequential insertion to satisfy foreign key constraints. |
| Provider Representation | Relies on Account object record types to differentiate HCPs (individuals) from HCOs (organizations) with custom metadata fields. | Utilizes the Provider Relationship Management model, distinctly separating the business entity from the clinical practitioner and their facilities. | Migration scripts must extract Veeva HCP Accounts, create an SFLSC Account, a Contact, a HealthcareProvider record, and generate the necessary affiliation junction objects. |
| Compliance & Consent | Isolated custom objects (Multichannel_Consent_vod__c) managing opt-ins, opt-outs, and paper consent IDs locally within the CRM application. | Standardized privacy schema utilizing AuthorizationFormConsent and AuthorizationFormDataUse, natively integrated with the Customer 360 data model. | Consent migration requires mapping historical timestamps and signatures to SFLSC polymorphic fields that can link to various underlying engagement objects across clouds. |
| Territory Management | Managed via proprietary custom fields (Territory_vod__c) and text-based alignment rules evaluated through custom Apex batch processes. | Natively integrated with standard Salesforce Enterprise Territory Management, utilizing standard Territory2 objects and rule engines. | String-based territory names in Veeva must be extracted, resolved against the SFLSC Territory2 relational database, and mapped via TerritoryId lookup fields. |
Entity Mapping and ERD View of Veeva CRM to SFLSC
1. Healthcare Provider (HCP) and Organization (HCO) Master Data Mapping
In the legacy Veeva ecosystem, HCPs and HCOs are primarily managed through the standard Salesforce Account object. The differentiation between a physician and a hospital is dictated by the RecordTypeId, with specialized attributes appended via the managed package. SFLSC fundamentally restructures this. The core business relationship remains on the Account, but the clinical identity, specializations, and operational statuses are offloaded to the HealthcareProvider object. The physical location of practice, stored as Address_vod__c in Veeva, translates into the HealthcareFacility object in SFLSC, while the relationship between the provider and the facility is captured via the HealthcarePractitionerFacility junction object.
| Veeva CRM Source Object & Field | Salesforce LSC Target Object | SFLSC Target Field / Attribute API Name | Target Data Type | Transformation Logic and Migration Narrative |
Account.Id | HealthcareProvider | SourceSystemIdentifier | String | Store the legacy 18-character Veeva ID for auditability, referential integrity during data loads, and delta synchronization. |
Account.RecordTypeId (HCP) | HealthcareProvider | ProviderType | Picklist | Transform the Veeva HCP record type string into the standardized SFLSC ProviderType picklist (e.g., Medical Doctor, Pharmacist, Ambulatory Care). |
Account.Credentials_vod__c | HealthcareProvider | ProfessionalTitle | Picklist | Map the practitioner’s credentials directly to ProfessionalTitle utilizing the standard value set HProviderProTitle. |
Account.Status_vod__c | HealthcareProvider | Status | Picklist | Map the operational state to HealthcareProvider.Status utilizing the HealthcareProviderStatus standard value set. |
Account.Furigana_vod__c | HealthcareProvider | PhoneticName or PhoneticName2 | String | For deployments in specific localizations (e.g., Japan), map phonetic sorting fields to facilitate text-based searches in SFLSC. |
Address_vod__c.Name | HealthcareFacility | Name | String | Extract the textual address identifier from Veeva and map to the primary name of the clinical facility. |
Address_vod__c.Account_vod__c | HealthcareFacility | AccountId | Master-Detail | Establish the critical linkage connecting the physical facility back to the overarching business organization account. |
Child_Account_vod__c.Parent_Account_vod__c & Child_Account_vod__c.Child_Account_vod__c | HealthcarePractitionerFacility | AccountId & PractitionerId | Lookup (Junction) | Veeva’s hierarchy records must be transformed into SFLSC junction records representing the formal affiliation between an HCP and their practicing HCO. |
TSF_vod__c.Last_Activity_Date_vod__c | Account or HealthcareProvider | LastActivityDate | Date | The Territory Specific Field tracking the last engagement must be evaluated. In SFLSC, this is often derived organically from Visit roll-ups rather than requiring a hardcoded field. |
2. Interaction Execution and Call Reporting Mapping
The most structurally complex and computationally intensive transformation involves the call reporting mechanism. Veeva’s Call2_vod__c object was designed to be flattened, handling high-level call details, sample drops, medical inquiries, and unique group activities within a single record or through tightly coupled, immediate child records to ensure rapid mobile saving. SFLSC shatters this flat structure into a strict execution hierarchy branching downward from the standard Salesforce Visit object.
The migration of a single Veeva Call requires the instantiation of a parent Visit record, followed immediately by the creation of a ProviderVisit extension record. The ProviderVisit object maintains a strict one-to-one relationship with the Visit object and serves as the repository for industry-specific compliance data, signature statuses, and confirmation flags. Subsequent to these two parent insertions, the ETL pipeline must iteratively generate execution child records.
| Veeva CRM Source Object & Field | Salesforce LSC Target Object | SFLSC Target Field / Attribute API Name | Target Data Type | Transformation Logic and Migration Narrative |
Call2_vod__c.Id | Visit | SourceSystemIdentifier | String | Retain the historical Veeva Call identifier to facilitate delta updates and ensure compliance traceability. |
Call2_vod__c.Account_vod__c | Visit | AccountId | Reference | Link the core visit event to the primary HCP or HCO with whom the interaction occurred. |
Call2_vod__c.Call_Datetime_vod__c | Visit | PlannedVisitStartTime | DateTime | Map the historical execution timestamp to the start time of the SFLSC visit execution record. |
Call2_vod__c.Status_vod__c | Visit | Status | Picklist | Map operational statuses (e.g., Planned, Saved, Submitted, Completed). Note that SFLSC defaults to ‘Planned’ upon standard creation. |
Call2_vod__c.Territory_vod__c | Visit | TerritoryId | Reference | This is a highly complex transformation. Veeva stores territory as a text string. The ETL middleware must execute a lookup against the SFLSC Territory2 object to retrieve and insert the corresponding relational ID. |
Call2_vod__c.Signature_Date_vod__c | Visit | SignatureType | Picklist | Map the presence of a signature to indicate whether compliance authorization was captured (Physical vs. Digital). |
| Architectural Requirement | ProviderVisit | VisitId | Master-Detail | SFLSC mandates the creation of this extension object. It maintains a strict 1:1 bond with Visit, storing regulatory and compliance details. |
Call2_vod__c.Medical_Inquiry_vod__c | ProviderVisit | AdditionalInformation | Textarea | Historical flags linking the call to a medical inquiry can be mapped here for auditability, or translated into full Inquiry relation structures. |
Call2_vod__c.Parenddress_Id_vod__c | Visit | PlaceId | Reference | Transform the legacy address ID string into a relational lookup mapping the visit to a specific Location or ContactPointAddress record. |
3. Product Detailing and Discussion Mapping
When an HCP is detailed on a specific therapeutic product, Veeva logs this interaction using the Call2_Detail_vod__c object, and tracks the specific marketing messaging delivered via the Call2_Key_Message_vod__c object. SFLSC handles these elements through specialized execution data child records that roll up to the ProviderVisit parent. This separation of concerns allows SFLSC to maintain a highly granular analytical data model, tracking exactly which product was discussed, the duration of the discussion, and the specific marketing asset utilized.
| Veeva CRM Source Object & Field | Salesforce LSC Target Object | SFLSC Target Field / Attribute API Name | Target Data Type | Transformation Logic and Migration Narrative |
Call2_Detail_vod__c.Product_vod__c | ProviderVisitProdDetailing | ProductId | Reference | Map the legacy product lookup to the SFLSC standard Product2 object representing the therapeutic asset detailed. |
Call2_Detail_vod__c.Call2_vod__c | ProviderVisitProdDetailing | ProviderVisitId | Master-Detail | Establish the hierarchical linkage ensuring the detailing event rolls up correctly to the parent interaction record. |
Call2_Key_Message_vod__c.Key_Message_Name_vod__c | ProviderVisitDtlProductMsg | ProviderVisitProductDtlId | Master-Detail | Transform the specific marketing message delivery record into an SFLSC object, linking it hierarchically to the overarching product detailing event. |
Call2_Key_Message_vod__c.Reaction_vod__c | ProviderVisitDtlProductMsg | ReactionType | Picklist | Map the qualitative assessment of the provider’s reaction (Positive, Neutral, Negative) to the SFLSC picklist for downstream AI sentiment analysis. |
4. Sample Management and PDMA Disbursements
Tracking the physical distribution of pharmaceutical drug samples is perhaps the most highly regulated workflow within commercial life sciences, governed strictly by the Prescription Drug Marketing Act (PDMA). Veeva handles this natively through embedded records within the Call object. SFLSC isolates this critical compliance data into dedicated inventory and disbursement objects, ensuring that sample limits, allocations, and discrepancy tracking are entirely decoupled from the subjective interaction log.
| Veeva Sample Source Object & Field | Salesforce LSC Target Object | SFLSC Target Field / Attribute API Name | Target Data Type | Transformation Logic and Migration Narrative |
Call2_Sample_vod__c.Call2_vod__c | ProductDisbursement | VisitId | Reference | Link the physical sample drop back to the core Visit record, establishing the primary audit trail for the interaction. |
Call2_Sample_vod__c.Sample_Quantity_vod__c | ProductDisbursement | Quantity | Number | Extract the exact quantity of therapeutic product disbursed and map it for downstream inventory reconciliation. |
Call2_Sample_vod__c.Limit_Applied_vod__c | PrvdVstSmplLmtTransaction | SampleLimitId | Reference | Map the historical sample limit validation check, linking the disbursement to the overarching sample limit engine to prove compliance at the time of distribution. |
| Inventory Allocation Calculation | TerritoryProdtQtyAllocation | Multiple Fields | Object | SFLSC requires the configuration of product quantity allocations per territory to validate against remaining limits. Historical Veeva allocations must be seeded here to ensure continuity. |
5. Multichannel Consent and Privacy Schema Mapping
Veeva’s Multichannel_Consent_vod__c object was historically responsible for capturing opt-ins, opt-outs, and storing identifiers for paper consents natively within the CRM application. SFLSC completely replaces this siloed approach with a highly normalized, platform-wide privacy schema utilizing the AuthorizationFormConsent object. This schema ensures that privacy preferences captured by a field representative are universally respected across Marketing Cloud, Service Cloud, and Data Cloud operations.
| Veeva Consent Source Object & Field | Salesforce LSC Target Object | SFLSC Target Field / Attribute API Name | Target Data Type | Transformation Logic and Migration Narrative |
Multichannel_Consent_vod__c.Account_vod__c | AuthorizationFormConsent | ConsentGiverId | Polymorphic | Link the consent record to the specific HCP or Contact granting authorization. This is a polymorphic field capable of linking to various entity types. |
Multichannel_Consent_vod__c.Consent_Type_vod__c | AuthorizationFormConsent | RelatedRecordId | Polymorphic | Map the type of consent to the specific AuthorizationFormText record, defining the exact legal language the HCP agreed to. |
Multichannel_Consent_vod__c.Capture_Datetime_vod__c | AuthorizationFormConsent | ConsentCapturedDateTime | DateTime | Extract the precise, immutable timestamp of the signature or opt-in for legal auditability. |
Multichannel_Consent_vod__c.Opt_Type_vod__c | AuthorizationFormConsent | Status | Picklist | Map the binary opt-in/opt-out status to SFLSC’s explicit privacy states (e.g., ‘Signed’, ‘Seen’, ‘Rejected’). |
Approach and Blueprint: Data Mapping, Transformation, and Validation
The physical transition of millions of records from the Force.com database hosting Veeva CRM to the modern Hyperforce infrastructure hosting SFLSC demands a meticulous architectural blueprint. This blueprint must ensure zero loss of regulatory audit trails, maintain referential integrity across deeply nested hierarchies, and navigate the complexities of SFLSC’s rigorous validation engines.
Field Mapping and Transformation Rules Execution
The execution of transformation rules requires enterprise-grade ETL middleware—such as MuleSoft Anypoint Platform or Informatica Intelligent Cloud Services—capable of executing complex mapping logic in transit.
The primary operational directive during this phase is Identifier Preservation. Every historical Veeva record extracted must retain its legacy Id (the standard 15- or 18-character Salesforce string). This identifier must be mapped to a custom Legacy_Veeva_Id__c field or the standard SourceSystemIdentifier field within the target SFLSC object. This singular architectural decision facilitates bidirectional delta synchronizations during the prolonged dual-run phase, enables rapid error reconciliation, and proves crucial for maintaining referential integrity when inserting child records.
Transformation logic must also accommodate complex one-to-many physical data splits. A single Call2_vod__c record extraction via the ETL pipeline cannot simply be inserted into a target table. The middleware must execute a sequential insertion pattern: first generating a Visit record, retrieving the newly generated SFLSC ID, subsequently inserting the corresponding ProviderVisit record, and iteratively generating ProviderVisitProdDetailing and ProductDisbursement records based on the original Veeva Call’s child structures. Furthermore, SFLSC utilizes polymorphic fields extensively throughout its architecture. For example, the AuthorizationFormConsent.RelatedRecordId field can point to an Account, a Visit, or an AuthorizationFormText record. Migration scripts must explicitly define the target object type during data insertion payloads to prevent catastrophic referential errors.
Validation Rules and Trigger Bypass Strategy
A critical hurdle in any CRM data migration of this magnitude is the enforcement of modern business logic and validation rules against historical, legacy data during bulk data loads. Unmanaged trigger executions during bulk API operations will inevitably cause CPU timeout limits, drastically reducing insertion throughput, and legacy Veeva data may fail newly implemented SFLSC validation parameters.
SFLSC provides native mechanisms to bypass trigger handlers during intensive migration activities. The optimal approach involves creating a dedicated migration user assigned the “Salesforce Integration” license type. Within this specific user profile, administrators must grant the “Salesforce API Integration” permission set license, which explicitly includes the Skip Life Sciences Cloud Trigger Handlers permission.
If finer control is required to test specific behaviors, enterprise architects can navigate to the Life Sciences Customer Engagement Admin Console to manually disable targeted trigger handlers. For example, disabling the ProductDisbursementSubmitLockHandler prevents the SFLSC system from locking historical sample disbursements when the related visit is marked as signed, allowing for subsequent historical data updates. Similarly, disabling the PVUpdateChildFieldsHandler prevents the system from automatically triggering synchronous updates to child provider visit records during the bulk load of parent visits, conserving critical CPU processing time.
Furthermore, historical legacy data presents a unique validation challenge. Records generated in Veeva five years ago often contain data configurations that were valid at the time but fail current organizational validation rules (e.g., an HCP with an inactive territory assignment or expired professional credentials). Validation rules in SFLSC must be augmented with logic to evaluate the execution context. By configuring validation rules to bypass evaluation if SourceSystemName equals “Veeva Legacy” or if a custom Is_Migration__c boolean flag evaluates to true, historical audit trails can be ingested in their original, immutable state without requiring artificial data manipulation to satisfy modern constraints.
Custom validation scripts, particularly those utilized on the SFLSC mobile application for Visit Action Validation, require careful handling. As demonstrated in SFLSC documentation, custom JavaScript components (e.g., visitSampleScript) evaluate in-memory execution data during visit submission. The script evaluates proxy arrays to determine the presence of product disbursements (`let sampleCount = productDisbursementData.length |
| 0;`). During the migration cutover, architects must ensure that historically migrated visit records do not inadvertently trigger these mobile-specific validation scripts when field users first open them, as the historical data shape may differ from the strict expectations of the new mobile validation logic.
Gap Analysis and Regulatory Risk Management
While Salesforce Life Sciences Cloud represents a formidable modernization of the technological stack, transitioning away from Veeva CRM exposes organizations to specific capability gaps that demand rigorous risk management and mitigation strategies. Veeva’s architecture was purpose-built exclusively for the life sciences regulatory environment; Salesforce provides a massive, scalable foundation that must be specifically configured, and often augmented, to achieve identical operational compliance.
Risk 1: 21 CFR Part 11 Compliance and Auditability
The Gap: Veeva CRM handles FDA 21 CFR Part 11 compliance—the rigorous standard governing electronic records and electronic signatures—as a foundational, out-of-the-box feature. While SFLSC and the broader Salesforce platform possess broad infrastructure certifications (e.g., ISO 27001, HIPAA), achieving specific GxP and Part 11 compliance at the application layer requires manual architectural implementation and continuous documentation.
Mitigation: Organizations must procure and actively configure Salesforce Shield. Shield provides the necessary architecture to capture encrypted, immutable audit trails of all field modifications, specifically targeting high-risk objects like AuthorizationFormConsent, Visit, and ProductDisbursement. Furthermore, IT compliance teams must design specific, validated re-authentication flows for electronic signature capture on mobile iPads to satisfy Part 11 requirements. The entire migration must be treated not merely as an IT upgrade, but as a fully validated GxP project requiring extensive documentation, testing protocols, and quality assurance oversight.
Risk 2: PDMA Sample Management Compliance
The Gap: The Prescription Drug Marketing Act (PDMA) demands rigorous tracking of pharmaceutical samples, mandated signature capture, and absolute inventory reconciliation. Veeva CRM natively includes deeply embedded sample tracking, allocation limits, and order management engines tailored explicitly to PDMA constraints. While SFLSC provides the structural data objects (ProductDisbursement, PrvdVstSmplLmtTransaction, SampleInventoryManagement) , the platform has historically required third-party integrations or heavy custom logic to mirror Veeva’s flawless real-time HCP license validation and strict field sample accountability workflows.
Mitigation: Enterprise architects must evaluate SFLSC’s evolving sample limits and product territory allocation features heavily during Phase 3. If native SFLSC validations are deemed insufficient for specific, highly regulated regional burdens, the architecture must proactively incorporate approved ISV (Independent Software Vendor) applications from the Salesforce AppExchange. These specialized applications handle PDMA compliance natively, encrypting signatures securely, and performing real-time, API-driven practitioner credential checks against state medical boards before allowing a ProductDisbursement record to be successfully submitted by a field representative.
Risk 3: Content Management Lifecycle (Veeva PromoMats vs. SFLSC)
The Gap: Veeva Vault CRM is intrinsically and natively linked to Veeva Vault PromoMats, establishing an unbroken, tightly controlled lifecycle for digital marketing content—from Medical, Legal, and Regulatory (MLR) review, through field distribution, to final expiry and automated withdrawal from the representative’s iPad. SFLSC currently features robust “Intelligent Content” modules, but it does not yet replicate the profound document storage capabilities, seamless metadata synchronization, and strict MLR version control natively provided by PromoMats out-of-the-box.
Mitigation: Organizations adopting SFLSC for commercial execution must adopt a hybrid enterprise architecture strategy. In this model, Veeva Vault PromoMats is deliberately retained as the system of record for all regulated content and MLR compliance approvals, while SFLSC serves purely as the intelligent engagement and execution hub. This requires building robust, fault-tolerant middleware connectors (utilizing MuleSoft APIs) to synchronize approved digital assets from PromoMats directly into SFLSC’s content repositories. This integration ensures that field representatives only possess access to compliant, currently approved e-detailing materials, automatically revoking access the moment an asset expires in PromoMats.
Risk 4: Clinical Trial and Medical Affairs Functionality
The Gap: Veeva offers deep, native integrations with its Vault Clinical suite (CTMS, eTMF), though its legacy CRM is largely commercial-focused. SFLSC aggressively targets this space with highly modern, native clinical modules (Participant Management, Care Program Management) built on FHIR standards. The risk here lies in the profound complexity of transitioning Medical Science Liaison (MSL) workflows, which rely on highly specialized medical inquiry logging, scientific slide libraries, and complex Key Opinion Leader (KOL) engagement plans that are not yet fully mature in SFLSC.
Mitigation: Phasing the rollout is the primary, non-negotiable risk mitigation strategy. Enterprise leadership must direct the migration of commercial operations (sales representatives, sample drops, general HCP detailing) to SFLSC first. The migration of Medical Affairs, MSL operations, and specialized KOL management must be delayed until SFLSC’s planned release of Medical Inquiry agents and dedicated KOL workflows (currently anticipated in the 2026 release cycles) are fully mature and battle-tested in the market. During the interim dual-run period, custom API integrations must be utilized to bridge the legacy medical functions residing in Veeva with the modernized commercial core operating in SFLSC.
The successful migration from Veeva CRM to Salesforce Life Sciences Cloud is a monumental architectural undertaking. By strictly adhering to this blueprint—respecting the fundamental conceptual shifts in the data model, meticulously mapping entity transformations, leveraging advanced Large Data Volume strategies, and proactively mitigating regulatory risks through hybrid integrations and phased cutovers—life sciences organizations can successfully navigate this transition, positioning themselves to leverage modern, AI-driven engagement ecosystems for the next decade of healthcare innovation.